News

Bivalent mRNA booster vaccines provide greater short-term protection against symptomatic COVID-19 infection

0
Scientist researcher chemist doctor working with transparent glassware mixing liquid solution during microbiology experiment in hospital laboratory. Medical equipment on table. Medicine concept

One of the first real-world data studies comparing the new bivalent mRNA COVID-19 booster vaccines with the original monovalent vaccines reports the bivalent conveyed greater short-term protection against symptomatic COVID-19 infection in adults.

The COVID-19 pandemic’s traumatizing effect on mothers in the USA

Previous article

Study investigates characteristics influencing the “belief in just deserts” regarding COVID-19 infection

Next article

You may also like

Comments

Leave a reply

Your email address will not be published. Required fields are marked *

More in News